Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Berberine Alleviates Olanzapine-Induced Adipogenesis via the AMPKα–SREBP Pathway in 3T3-L1 Cells
Yan-Jie Li, Xiaomin Zhao, Xiyu Feng, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 11, pp. 1865-1865
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
Xiaojun Feng, Antoni Sureda, Samineh Jafari, et al.
Theranostics (2019) Vol. 9, Iss. 7, pp. 1923-1951
Open Access | Times Cited: 326
Metabolic Syndrome Exacerbates Pulmonary Hypertension due to Left Heart Disease
Benoît Ranchoux, Valérie Nadeau, Alice Bourgeois, et al.
Circulation Research (2019) Vol. 125, Iss. 4, pp. 449-466
Open Access | Times Cited: 89
Bioactive compounds from herbal medicines to manage dyslipidemia
Xinyu Ji, Shuai Shi, Bin Liu, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 118, pp. 109338-109338
Open Access | Times Cited: 83
Natural alkaloid and polyphenol compounds targeting lipid metabolism: Treatment implications in metabolic diseases
Can Cheng, Zhenzhen Li, Xu Zhao, et al.
European Journal of Pharmacology (2020) Vol. 870, pp. 172922-172922
Closed Access | Times Cited: 63
A New Therapeutic Candidate for Cardiovascular Diseases: Berberine
Yun Cai, Qiqi Xin, Jinjin Lu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 50
Olanzapine-induced lipid disturbances: A potential mechanism through the gut microbiota-brain axis
Zhenyu Zhu, Yuxiu Gu, Cuirong Zeng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
Protein Kinases in Obesity, and the Kinase-Targeted Therapy
Atilla Engin
Advances in experimental medicine and biology (2024), pp. 199-229
Closed Access | Times Cited: 6
Antipsychotics Promote Metabolic Disorders Disrupting Cellular Lipid Metabolism and Trafficking
Chiara Vantaggiato, Elena Panzeri, Andrea Citterio, et al.
Trends in Endocrinology and Metabolism (2019) Vol. 30, Iss. 3, pp. 189-210
Closed Access | Times Cited: 44
Berberine mitigates nonalcoholic hepatic steatosis by downregulating SIRT1-FoxO1-SREBP2 pathway for cholesterol synthesis
Meng-ya Shan, Ying Dai, Xiaodan Ren, et al.
Journal of Integrative Medicine (2021) Vol. 19, Iss. 6, pp. 545-554
Closed Access | Times Cited: 34
Panax notoginsengSaponin Protects Against Diabetic Cardiomyopathy Through Lipid Metabolism Modulation
Chenyang Zhang, Bin Zhang, Xuelian Zhang, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 4
Open Access | Times Cited: 26
Olanzapine, risperidone and ziprasidone differently affect lysosomal function and autophagy, reflecting their different metabolic risk in patients
Marco Pozzi, Chiara Vantaggiato, F Brivio, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Curcumin Activates AMPK Pathway and Regulates Lipid Metabolism in Rats Following Prolonged Clozapine Exposure
Zhen Liu, Changmeng Cui, Pengfei Xu, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 45
Bilobalide Suppresses Adipogenesis in 3T3-L1 Adipocytes via the AMPK Signaling Pathway
Su Bu, Chun Ying Yuan, Xue Quan, et al.
Molecules (2019) Vol. 24, Iss. 19, pp. 3503-3503
Open Access | Times Cited: 38
Effect of Quercetin on Lipids Metabolism Through Modulating the Gut Microbial and AMPK/PPAR Signaling Pathway in Broilers
Mi Wang, Bo Wang, Shanshan Wang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 31
A phenotypic Caenorhabditis elegans screen identifies a selective suppressor of antipsychotic-induced hyperphagia
Anabel Pérez‐Gómez, Maria Carretero, Natalie Weber, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 32
Epigenetic histone modulations of PPARγ and related pathways contribute to olanzapine-induced metabolic disorders
Yueqing Su, Xuemei Liu, Jiamei Lian, et al.
Pharmacological Research (2020) Vol. 155, pp. 104703-104703
Closed Access | Times Cited: 32
A potential probiotic bacterium for antipsychotic-induced metabolic syndrome: mechanisms underpinning how Akkermansia muciniphila subtype improves olanzapine-induced glucose homeostasis in mice
Dongquan Huang, Jie Gao, Chong Li, et al.
Psychopharmacology (2021) Vol. 238, Iss. 9, pp. 2543-2553
Closed Access | Times Cited: 24
Validation of a Quantification Method for Curcumin Derivatives and Their Hepatoprotective Effects on Nonalcoholic Fatty Liver Disease
Young-Seob Lee, Seon Min Oh, Qianqian Li, et al.
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 1, pp. 409-432
Open Access | Times Cited: 16
The regulatory effects of second-generation antipsychotics on lipid metabolism: Potential mechanisms mediated by the gut microbiota and therapeutic implications
Hui Chen, Ting Cao, Bikui Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Berberine Protects Against Palmitate-Induced Apoptosis in Tubular Epithelial Cells by Promoting Fatty Acid Oxidation
Ji-ye Sun, Xuemei Chen, Ting Liu, et al.
Medical Science Monitor (2018) Vol. 24, pp. 1484-1492
Open Access | Times Cited: 29
The design and synthesis of a novel compound of berberine and baicalein that inhibits the efficacy of lipid accumulation in 3T3-L1 adipocytes
Mengjiao Hao, Yan Li, Lixian Liu, et al.
Bioorganic & Medicinal Chemistry (2017) Vol. 25, Iss. 20, pp. 5506-5512
Closed Access | Times Cited: 26
Gentiopicroside Ameliorates the Progression from Hepatic Steatosis to Fibrosis Induced by Chronic Alcohol Intake
Hongxu Yang, Yue Shang, Quan Jin, et al.
Biomolecules & Therapeutics (2020) Vol. 28, Iss. 4, pp. 320-327
Open Access | Times Cited: 23
Current Evidence of Natural Products against Overweight and Obesity: Molecular Targets and Mechanisms of Action
Cristina Alicia Elizalde-Romero, Nayely Leyva‐López, Laura Aracely Contreras-Angulo, et al.
Receptors (2024) Vol. 3, Iss. 3, pp. 362-379
Open Access | Times Cited: 2
Berberine attenuated olanzapine-induced metabolic alterations in mice: Targeting transient receptor potential vanilloid type 1 and 3 channels
Raghunath Singh, Yashika Bansal, Rupinder Kaur Sodhi, et al.
Life Sciences (2020) Vol. 247, pp. 117442-117442
Closed Access | Times Cited: 20
The effect of berberine adjunctive treatment on glycolipid metabolism in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial
Meijuan Li, Ying Liu, Yuying Qiu, et al.
Psychiatry Research (2021) Vol. 300, pp. 113899-113899
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top